Aveanna Healthcare's Stock Rises with Strong Q4 Results

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) shares surged by 35% following the announcement of fourth-quarter and full-year 2024 financial results that exceeded analyst expectations, along with positive projections for 2025. The company reported earnings per share (EPS) of $0.05 for the fourth quarter, surpassing the analyst forecast of $0.00. Revenue reached $519.9 million, exceeding the consensus estimate of $499.07 million and reflecting an 8.6% increase year-over-year, driven primarily by significant growth in the Specialty Services segment.

CEO Jeff Shaner emphasized that the fourth quarter reflected strong operational and financial results in what he termed a transformative year for Aveanna. The company anticipates 2025 revenue between $2.1 billion and $2.12 billion, closely aligning with the consensus estimate of $2.11 billion. CFO Matt Buckhalter expressed satisfaction with revenue growth and adjusted EBITDA increases, attributing success to strategic cost reductions and enhanced payer relationships. Investors reacted positively to the company’s strong financial performance and optimistic guidance for sustained growth and profitability in the upcoming fiscal year.